NASDAQ: APVO
Aptevo Therapeutics Inc Stock Ownership - Who owns Aptevo Therapeutics?

Insider buying vs selling

Have Aptevo Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Dirk HuebnerCMO;SVP2026-08-06156$4.07
$634.92Sell
Marvin L. WhiteChair2026-08-06406$4.07
$1.65kSell
Grady Grant IiiDirector2025-11-1013,513$1.49
$20.13kBuy

1 of 1

APVO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when APVO insiders and whales buy or sell their stock.

APVO Shareholders

What type of owners hold Aptevo Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fuad Elhibri167.70%3,021,899$5.56MInsider
Scott C. Stromatt12.00%216,183$397.78kInsider
Jane A. Gross6.08%109,583$201.63kInsider
Niowave Inc5.47%98,522$181.28kInsider
Shawnte Mitchell4.47%80,527$148.17kInsider
Randy Joe Maddux4.16%75,000$138.00kInsider
Michael Adelman3.91%70,426$129.58kInsider
Marvin L. White0.07%1,261$2.32kInsider
Grady Grant Iii0.06%1,150$2.12kInsider
Jeffrey G. Lamothe0.05%961$1.77kInsider

1 of 3

APVO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
APVO0.00%100.00%Net BuyingNet Selling
XRTX0.00%0.00%
SXTP0.01%99.99%Net Buying
VIVS0.00%100.00%Net BuyingNet Buying
EOCN0.02%21.22%

Aptevo Therapeutics Stock Ownership FAQ

Who owns Aptevo Therapeutics?

Aptevo Therapeutics (NASDAQ: APVO) is owned by 0.00% institutional shareholders, 204.16% Aptevo Therapeutics insiders, and 0.00% retail investors. Fuad Elhibri is the largest individual Aptevo Therapeutics shareholder, owning 3.02M shares representing 167.70% of the company. Fuad Elhibri's Aptevo Therapeutics shares are currently valued at $5.56M.

If you're new to stock investing, here's how to buy Aptevo Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.